Advertisement
Screener

Skye Bioscience, Inc. (SKYE) Basic Shares Outstanding (Weighted Average)

2.8 / 5 stars · 68/120 Roast Me

Skye Bioscience, Inc. Basic Shares Outstanding (Weighted Average)

Skye Bioscience, Inc. (SKYE) reported Basic Shares Outstanding (Weighted Average) of 39.69 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14

  • Skye Bioscience, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 39.69M shares, a 0.09% increase year-over-year.
  • Skye Bioscience, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 39.68M shares, a 0.07% increase year-over-year.
  • Skye Bioscience, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 39.69M shares, a 0.77% decline year-over-year.
  • Skye Bioscience, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 39.67M shares, a 2.18% increase year-over-year.
  • Skye Bioscience, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 39.66M shares, a 8.70% increase from fiscal 2024.
  • Skye Bioscience, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 36.49M shares, a 420.79% increase from fiscal 2023.
  • Skye Bioscience, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 7.01M shares, a 215.43% increase from fiscal 2022.
  • Skye Bioscience, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 2.22M shares, a 99.45% decline from fiscal 2021.
Period endWeighted Average Number of Shares Outstanding, Basic 3 monthWeighted Average Number of Shares Outstanding, Basic 3 month as first filedWeighted Average Number of Shares Outstanding, Basic 6 monthWeighted Average Number of Shares Outstanding, Basic 6 month as first filedWeighted Average Number of Shares Outstanding, Basic 9 monthWeighted Average Number of Shares Outstanding, Basic 9 month as first filedWeighted Average Number of Shares Outstanding, Basic 12 monthWeighted Average Number of Shares Outstanding, Basic 12 month as first filed
2026-06-3039.69M shares
10-Q · filed 2026-08-14
39.69M shares
10-Q · filed 2026-08-14
39.69M shares
derived: average of 3 quarters · filed 2026-08-14
39.68M shares
derived: average of 4 quarters · filed 2026-08-14
2026-03-3139.68M shares
10-Q · filed 2026-05-11
39.68M shares
derived: average of 2 quarters · filed 2026-05-11
39.68M shares
derived: average of 3 quarters · filed 2026-05-11
39.67M shares
derived: average of 4 quarters · filed 2026-08-14
2025-12-3139.69M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10
39.68M shares
derived: average of 2 quarters · filed 2026-03-10
39.67M shares
derived: average of 3 quarters · filed 2026-08-14
39.66M shares
10-K · filed 2026-03-10
2025-09-3039.67M shares
10-Q · filed 2025-11-10
39.66M shares
derived: average of 2 quarters · filed 2026-08-14
39.65M shares
10-Q · filed 2025-11-10
39.74M shares
derived: average of 4 quarters · filed 2026-08-14
2025-06-3039.66M shares
10-Q · filed 2026-08-14
39.66M shares
10-Q · filed 2026-08-14
39.77M shares
derived: average of 3 quarters · filed 2026-08-14
39.53M shares
derived: average of 4 quarters · filed 2026-08-14
2025-03-3139.65M shares
10-Q · filed 2026-05-11
39.82M shares
derived: average of 2 quarters · filed 2026-05-11
39.49M shares
derived: average of 3 quarters · filed 2026-05-11
39.28M shares
derived: average of 4 quarters · filed 2026-05-11
2024-12-3139.99M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10
39.41M shares
derived: average of 2 quarters · filed 2026-03-10
39.16M shares
derived: average of 3 quarters · filed 2026-03-10
36.49M shares
10-K · filed 2026-03-10
2024-09-3038.82M shares
10-Q · filed 2025-11-10
38.74M shares
derived: average of 2 quarters · filed 2025-11-10
35.32M shares
10-Q · filed 2025-11-10
29.47M shares
derived: average of 4 quarters · filed 2025-11-10
2024-06-3038.67M shares
10-Q · filed 2025-08-07
33.33M shares
10-Q · filed 2025-08-07
26.36M shares
derived: average of 3 quarters · filed 2025-08-07
21.74M shares
derived: average of 4 quarters · filed 2025-08-07
2024-03-3128.00M shares
10-Q · filed 2025-05-08
20.20M shares
derived: average of 2 quarters · filed 2025-05-08
16.09M shares
derived: average of 3 quarters · filed 2025-05-08
13.04M shares
derived: average of 4 quarters · filed 2025-05-08
2023-12-3112.40M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20
10.14M shares
derived: average of 2 quarters · filed 2025-03-20
8.06M shares
derived: average of 3 quarters · filed 2025-03-20
7.01M shares
10-K · filed 2025-03-20
2023-09-307.88M shares
10-Q · filed 2024-11-07
5.88M shares
derived: average of 2 quarters · filed 2024-11-07
5.21M shares
10-Q · filed 2024-11-07
4.62M shares
derived: average of 4 quarters · filed 2024-11-07
2023-06-303.89M shares
10-Q · filed 2024-08-09
971.55M shares
10-Q · filed 2023-08-07
3.83M shares
10-Q · filed 2024-08-09
956.80M shares
10-Q · filed 2023-08-07
3.53M shares
derived: average of 3 quarters · filed 2024-08-09
3.14M shares
derived: average of 4 quarters · filed 2024-08-09
2023-03-313.77M shares
10-Q · filed 2024-05-10
941.89M shares
10-Q · filed 2023-05-12
3.35M shares
derived: average of 2 quarters · filed 2024-05-10
2.89M shares
derived: average of 3 quarters · filed 2024-05-10
126.15M shares
derived: average of 4 quarters · filed 2024-05-10
2022-12-312.93M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22
2.46M shares
derived: average of 2 quarters · filed 2024-03-22
166.95M shares
derived: average of 3 quarters · filed 2024-03-22
2.22M shares
10-K · filed 2024-03-22
555.27M shares
10-K · filed 2023-03-31
2022-09-301.98M shares
10-Q · filed 2023-11-14
495.93M shares
10-Q · filed 2022-11-14
248.95M shares
derived: average of 2 quarters · filed 2023-11-14
1.98M shares
10-Q · filed 2023-11-14
495.89M shares
10-Q · filed 2022-11-14
372.62M shares
derived: average of 4 quarters · filed 2023-11-14
2022-06-30495.93M shares
10-Q · filed 2023-08-07
495.87M shares
10-Q · filed 2023-08-07
496.17M shares
derived: average of 3 quarters · filed 2023-08-07
475.50M shares
derived: average of 4 quarters · filed 2023-08-07
2022-03-31495.82M shares
10-Q · filed 2023-05-12
496.29M shares
derived: average of 2 quarters · filed 2023-05-12
468.69M shares
derived: average of 3 quarters · filed 2023-05-12
446.12M shares
derived: average of 4 quarters · filed 2023-05-12
2021-12-31496.76M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
455.12M shares
derived: average of 2 quarters · filed 2023-03-31
429.56M shares
derived: average of 3 quarters · filed 2023-03-31
406.60M shares
10-K · filed 2023-03-31
2021-09-30413.49M shares
10-Q · filed 2022-11-14
395.96M shares
derived: average of 2 quarters · filed 2022-11-14
376.55M shares
10-Q · filed 2022-11-14
357.29M shares
derived: average of 4 quarters · filed 2022-11-14
2021-06-30378.43M shares
10-Q · filed 2022-08-15
357.77M shares
10-Q · filed 2022-08-15
338.56M shares
derived: average of 3 quarters · filed 2022-08-15
318.11M shares
derived: average of 4 quarters · filed 2022-08-15
2021-03-31336.88M shares
10-Q · filed 2022-05-06
318.63M shares
derived: average of 2 quarters · filed 2022-05-06
298.01M shares
derived: average of 3 quarters · filed 2022-05-06
269.27M shares
derived: average of 4 quarters · filed 2022-05-06
2020-12-31300.38M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28
278.57M shares
derived: average of 2 quarters · filed 2022-03-28
246.73M shares
derived: average of 3 quarters · filed 2022-03-28
230.75M shares
10-K · filed 2022-03-28
2020-09-30256.76M shares
10-Q · filed 2021-11-10
219.91M shares
derived: average of 2 quarters · filed 2021-11-10
207.54M shares
10-Q · filed 2021-11-10
191.01M shares
derived: average of 4 quarters · filed 2021-11-10
2020-06-30183.05M shares
10-Q · filed 2021-08-06
182.65M shares
10-Q · filed 2021-08-06
169.09M shares
derived: average of 3 quarters · filed 2021-08-06
160.07M shares
derived: average of 4 quarters · filed 2021-08-06
2020-03-31182.26M shares
10-Q · filed 2021-05-07
162.11M shares
derived: average of 2 quarters · filed 2021-05-07
152.41M shares
derived: average of 3 quarters · filed 2021-05-07
147.54M shares
derived: average of 4 quarters · filed 2021-05-07
2019-12-31141.96M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02
137.48M shares
derived: average of 2 quarters · filed 2021-03-02
135.96M shares
derived: average of 3 quarters · filed 2021-03-02
135.15M shares
10-K · filed 2021-03-02
2019-09-30133.00M shares
10-Q · filed 2020-11-06
132.96M shares
derived: average of 2 quarters · filed 2020-11-06
132.89M shares
10-Q · filed 2020-11-06
132.74M shares
derived: average of 4 quarters · filed 2020-11-06
2019-06-30132.92M shares
10-Q · filed 2020-08-13
132.83M shares
10-Q · filed 2020-08-13
132.66M shares
derived: average of 3 quarters · filed 2020-08-13
132.35M shares
derived: average of 4 quarters · filed 2020-08-13
2019-03-31132.73M shares
10-Q · filed 2020-05-08
132.52M shares
derived: average of 2 quarters · filed 2020-05-08
132.16M shares
derived: average of 3 quarters · filed 2020-05-08
131.79M shares
derived: average of 4 quarters · filed 2020-05-08
2018-12-31132.31M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23
131.88M shares
derived: average of 2 quarters · filed 2020-03-23
131.48M shares
derived: average of 3 quarters · filed 2020-03-23
121.15M shares
10-K · filed 2020-03-23
2018-09-30131.45M shares
10-Q · filed 2019-11-14
131.06M shares
derived: average of 2 quarters · filed 2019-11-14
117.43M shares
10-Q · filed 2019-11-14
95.29M shares
derived: average of 4 quarters · filed 2019-11-14
2018-06-30130.67M shares
10-Q · filed 2019-08-09
109.77M shares
10-Q · filed 2019-08-09
83.24M shares
derived: average of 3 quarters · filed 2019-08-09
69.98M shares
derived: average of 4 quarters · filed 2019-08-09
2018-03-3188.63M shares
10-Q · filed 2018-05-15
59.53M shares
derived: average of 2 quarters · filed 2018-05-15
49.75M shares
derived: average of 3 quarters · filed 2018-11-14
44.41M shares
derived: average of 4 quarters · filed 2018-11-14
2017-12-3130.42M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19
30.31M shares
derived: average of 2 quarters · filed 2018-11-14
29.66M shares
derived: average of 3 quarters · filed 2018-11-14
27.91M shares
10-K · filed 2018-03-19
2017-09-3030.19M shares
10-Q · filed 2018-11-14
29.28M shares
derived: average of 2 quarters · filed 2018-11-14
27.07M shares
10-Q · filed 2018-11-14
24.47M shares
derived: average of 4 quarters · filed 2018-11-14
2017-06-3028.38M shares
10-Q · filed 2018-08-10
25.81M shares
10-Q · filed 2018-08-10
22.56M shares
derived: average of 3 quarters · filed 2018-08-10
21.90M shares
derived: average of 4 quarters · filed 2018-08-10
2017-03-3123.25M shares
10-Q · filed 2018-05-15
19.65M shares
derived: average of 2 quarters · filed 2018-05-15
19.74M shares
derived: average of 3 quarters · filed 2018-05-15
19.78M shares
derived: average of 4 quarters · filed 2018-05-15
2016-12-3116.06M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19
17.99M shares
derived: average of 2 quarters · filed 2018-03-19
18.63M shares
derived: average of 3 quarters · filed 2018-03-19
18.95M shares
10-K · filed 2018-03-19
2016-09-3019.91M shares
10-Q · filed 2017-11-14
19.91M shares
derived: average of 2 quarters · filed 2017-11-14
19.91M shares
10-Q · filed 2017-11-14
2016-06-3019.91M shares
10-Q · filed 2017-08-11
19.91M shares
10-Q · filed 2017-08-11
2015-06-3016.27M shares
10-Q · filed 2016-08-12
16.25M shares
10-Q · filed 2016-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
CalciMedica, Inc. (CALC)United States$0.061B-1.42
TALPHERA, INC. (TLPH)United States$0.060B
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
HYPERION DEFI, INC. (HYPD)United States$0.065B
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
XBiotech Inc. (XBIT)United States$0.066B-1.56
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Clene Inc. (CLNN)United States$0.054B-1.99